Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 11.06.2008 Kleinostheim, June 11, 2008 - Curasan AG (ISIN: DE 000 549 453 8), listed in the Prime Standard, has sold its dental division to Riemser Arzneimittel AG, Greifswald, effective from July 1, 2008. The earnings expected therefrom will ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. quaterly report 25.04.2008 Kleinostheim, 25 April 2008 - curasan AG (ISIN: DE 000 549 453 8) has succeeded in increasing its revenues of Q1/2008 by 13% compared to Q1/2007 from 2.6 million ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. New Products 12.03.2008 curasan AG (ISIN DE 000 549 453 8) listed in the Prime Standard signed a distributorship agreement with Osteogenics Biomedical Inc., Lubbock, Texas, USA. Thereby, curasan is granted the distribution rights for a powerful ...
Tip announcement for financial statements transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The financial statement is available: in the internet at: http://www.curasan.de/com/investor_relations/quarterly_reports.php in the internet on: 10.08.2007 end of ...
Notification concerning transactions by persons discharging managerial responsibilities pursuant to section 15a of the WpHG, transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. 14.06.2007 Xetra (euro adhoc) - Details of the person subject to the disclosure requirement: Name: Hans Dieter Rössler Name of ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. new product Kleinostheim (euro adhoc) - curasan AG, a German leader in regenerative medicine, has obtained FDA clearance for its REVOIS® All-in-One dental implant system, permitting the sale of the system in the U.S. This means that the system can be ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Marketing 12.06.2007 curasan AG (ISIN DE 000 549 453 8) listed in the Prime Standard obtained the FDA-certification for her REVOIS® dental implant system. By this, the medical product is registered for distribution in the United States of ...
Tip announcement for financial statements transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The financial statement is available: in the internet at: http://www.curasan.de/com/investor_relations/quarterly_reports.php in the internet on: 11.05.2007 end of ...
Notification of voting rights transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Person/company obliged to make the notification: Name: Gebhard & Co. Wertpapierhandelsbank AG Place: Gräfelfing State: Germany Company data: Name: curasan AG Address: ...
Notification of voting rights transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Person/company obliged to make the notification: Name: Hans Dieter Rössler State: Germany Company data: Name: curasan AG Address: Lindigstrasse 4, 63801 Kleinostheim Place: ...
Notification concerning transactions by persons discharging managerial responsibilities pursuant to section 15a of the WpHG, transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. 24.04.2007 off-market (euro adhoc) - end of announcement euro adhoc 25.04.2007 18:01:21 ots Originaltext: curasan AG Im ...
Notification of voting rights transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Person/company obliged to make the notification: Name: Gebhard & Co. Wertpapierhandelsbank AG Place: Gräfelfing State: Germany Company data: Name: curasan AG Address: ...
Total number of voting rights announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. curasan AG hereby announces that at the end of the month March 2007 the number of voting rights amounts to a total of 6775000 voting rights. The change of total voting rights ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. cooperations Kleinostheim (euro adhoc) - curasan AG (WKN 549 453 8) has been granted worldwide distribution rights by Kensey Nash Corporation, USA, for Epi-Guide®, their bioresorbable membrane. This is an extension to a cooperation established in 2001 which has, so far, comprised sales in Germany, ...
Tip announcement for financial statements transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The financial statement is available: in the internet at: http://www.curasan.de/com/investor_relations/annual_reports.php in the internet on: 27.03.2007 end of ...
Notification of voting rights transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Person/company obliged to make the notification: Name: Hans Dieter Rössler State: Germany Company data: Name: curasan AG Address: Lindigstrasse 4, 63801 Kleinostheim Place: ...
Notification of voting rights transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Person/company obliged to make the notification: Name: Hans Dieter Rössler Address: ---- Place: ---- State: Germany Company data: Name: curasan AG Address: Lindigstrasse 4, ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 01.03.2007 Kleinostheim, March 1, 2007 - Today, curasan AG (ISIN DE 000 549 453 8) listed in the Prime Standard, has placed 525,000 new ordinary shares, in the form of bearer shares, as a capital increase against cash. This capital increase was ...
Notification of voting rights transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Person/company obliged to make the notification: Name: Rössler, Hans Dieter Address: Auerbachstr. 2 Place: 63856 Bessenbach State: Germany Company data: Name: curasan AG Address: Lindigstrasse 4, 63801 Kleinostheim Place: Kleinostheim State: Deutschland 01.03.2007 Stock of ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 15.12.2006 Ad hoc announcement pursuant to Section 15 WpHG Kleinostheim, December 15, 2006 - curasan AG (ISIN: DE 000 549 453 8), a company listed in the Prime Standard, has concluded an agreement with the licensor of the REVOIS® implant system ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 10.11.2005 Kleinostheim, November 10, 2005 - curasan AG (ISIN DE 000 549 453 8) listed in the Prime Standard, is going to expand its product line by a dental implant system. The REVOIS ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 09.11.2005 Kleinostheim, November 9, 2005 - Today, curasan AG (ISIN DE 000 549 453 8) listed in the Prime Standard, has placed 500,000 new ordinary shares, in the form of bearer shares, as a capital increase. This capital increase was submitted to ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 27.07.2005 curasan AG - specialists in regenerative medicine - today received 510(k) approval by the FDA for Cerasorb® M Dental and Cerasorb® Perio. Cerasorb® is a synthetic bone ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 21.07.2005 Kleinostheim, July 21, 2005 - curasan AG (WKN 549 453) today announced its financial results for the second quarter ended June 30, 2005. In the second quarter, the company generated ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 23.05.2005 Kleinostheim, May 23, 2005 - curasan AG (WKN 549 453), a company specialising in regenerative medicine, has today placed 250,000 new ordinary shares, in the form of bearer shares, as part of an increase in capital decided upon by the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 12.05.2005 Kleinostheim, May 12, 2005 - curasan AG (WKN 549 453) today announced its financial results for the first quarter ended March 31, 2005. In the first three months of the 2005 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 25.02.2005 Kleinostheim, February 25, 2005 - curasan AG (WKN 549 453) today announced its preliminary results for the 2004 financial year. As regards year-on-year comparisons, it should be noted that the Pharmaceuticals business unit ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Kleinostheim, November 9, 2004 curasan AG (WKN 549 453) today announced its preliminary results for the first nine months ended September 30, 2004. As regards year-on-year comparisons, it ...